Allergy Diagnostics And Therapeutics Market (By Product: Services, Consumables, Instruments; By Allergen Type: Food, Drug, Inhaled, Other; By End Use: Diagnostic Laboratories, Hospitals, Academic Research Institutes; By Test: In vitro Test, In vivo Test [Intradermal Test, Skin Prick Test, Patch Test]; By Drug Class: Corticosteroids, Mast Cell Stabilizers, Antihistamines, Decongestants, Leukotriene Inhibitors, Autoinjectable Epinephrine, Nasal Anticholinergics, Immunotherapy, Immunomodulators) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

According to Acumen Research and Consulting, the global Allergy Diagnostics And Therapeutics market is expected to grow at noteworthy CAGR around 6 % throughout the forecast period and reach around US$ 50.9 billion by 2026.

The report provides analysis of global Allergy Diagnostics And Therapeutics market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.

Market Dynamics

The sector development in the coming years is expected to drive increasing incidences of allergic illnesses and high demand for in vitro-diagnostic blood exams.

In 2012, approximately 40 million instances of inhaled allergies were recorded in the USA and the figure was rising, according to estimates released by the World Health Organization (WHO). In this sector, the figure is growing. In addition, the effects of allergic conditions are projected to rise, such as a change of lifestyle, growing rates of pollution in the indoor and outdoor areas, bad eating practices and fast urbanization worldwide.

In turn, this will assist in the next few years to increase the development of the industry. The introduction of extremely delicate and precise diagnostic and therapeutic goods which is anticipated to have a beneficial effect on worldwide market over the predictable era.
Segment of the inhaled allergen type was the biggest market share in 2018 and will continue to dominate the expected years. The growing instances of respiratory allergies can be ascribed to this development. Around 7,8 million kids globally suffered from respiratoric allergies, according to statistics released by the United States Academy for Allergy Asthma and Immunology (AAAI), in 2012.

Diagnostic Test Outlook

Due to the related advantages like ease of use, time effectiveness, broader accessibility and clinically valid allergy awareness the in vitro test was the biggest test segment in 2018. Due to increased acceptance by health practitioners and patients, Skin Prick Test accounted for the biggest share of income in 2018. At the largest CAGR of around 11,0%, the section is expected to grow further from 2019 to 2026.

This is largely due to the increased applicability of skin prick tests to detect food allergies, particular allergy tests mediated by IgE. It is also anticipated that the In vitro test segment will see substantial development in coming years as demand for less invasive diagnostic techniques, laboratory automation and extremely delicate and precise outcomes will rise. Market companies also focus on offering allergy-specific alternatives and precise results-based devices in order to achieve the highest market share.

Product Stance

Instruments, consumables and services include in the product section. Consumables resulted the entire industry in 2018, because the detection of allergies is a crucial element. The segment is planned to be further driven by technological advancements such as more delicate allergens microarrays, offering individual patient profiling and tracking. Furthermore, product adventures such as MeDALL allergy chip with improved sensitivity specificity and quicker diagnosis are planned to promote market growth.

Allergen Type Stance

The market is classified in food, inhalation, drug and others based on allergens. Inhaled allergens resulted to an enhanced incidence of pulmonary allergy and asthma worldwide in the globally market in allergy diagnostics and therapeutic products in 2018. Due to the elevated demands for allergy testing and the introduction of special allergens for allergy identification, the section will grow further in the fastest CAGR.

A powerful CAGR of more than 11% is also anticipated in the 2019-2026 drug-allergy section. In terms of income, food allergies were the second largest sector and will persist in the following years. These kinds of allergic disease are more vulnerable for children. The estimates released by the United States show. The incidence of food allergies in kids is double those in adults at National Health Institute (NIH).

Drug Class Stance

Due to their related advantages and widespread applications in the therapy of allergy illnesses, antihistamines represented the greatest market share in 2018. The estimated impact of allergic rhinitis on roughly 10.0 to 30.0 per cent of the worldwide population is based on the American Academy of Allergies Asthma and immunology (AAAAI), which contributes to the acceptance of allergy therapys. Factors such as lifestyles change, bad nutritional practices and increasing concentrations of pollution are key causes of allergic circumstances.

The market is anticipated to increase over the forecast period by the introduction of sophisticated therapeutic medicinal products, for example monoclonal antibodies with greater efficacy than standard drugs. The most rapidly growing segment of immunotherapy is anticipated to have CAGRs of around 7 per cent between 2019 and 2026, as demand for sublingual vaccines is rising, a large number of medication pipelines is underway, and monoclonal antibodies for patient therapy are being monoclonalized.

End Use Stance

The market is divided into hospitals, academic research institute, and diagnostic laboratories based on end use. The most comprehensive use in diagnostic immunoassay studies in allergy diagnosis was in diagnostic laboratory settings of around 48 percent in 2018. The segment will be driven further by the advances in screening methods that allow precise diagnosis and stratification for proper therapy. The most rapidly growing segment is anticipated to be hospitals because of supportive public financing and increased health expenditure.

Regional Stance

As a result of elevated incidences of respiratory allergic illnesses, and increased awareness of the allergy diagnostic concentrations and the use of in vitro blood exams, North America resulted the worldwide income market in 2018. Due to the existence of the advanced pharmaceutical sector and growing demand for therapeutics, Europe is anticipated to be the second largest regional market. The development of the region is also driven by the growing geriatric populations and increased incidences of allergic conditions. The quickly improving health infrastructures and unmet clinic requirements are the most promising regional markets with a CAGR of approximately 13 percent between 2019 and 2026 owing to demand for minimally invasive diagnostic instruments. Asia Pacific is the fastest growing regional market.

Market Segmentation

Global Allergy Diagnostics And Therapeutics Market, By Product

• Services
• Consumables
• Instruments

Global Allergy Diagnostics And Therapeutics Market, By Allergen Type

• Food
• Drug
• Inhaled
• Other

Global Allergy Diagnostics And Therapeutics Market, By End Use

• Diagnostic Laboratories
• Hospitals
• Academic Research Institutes

Global Allergy Diagnostics And Therapeutics Market, By Test

• In vitro Test
• In vivo Test
  
  • Intradermal Test
  • Skin Prick Test
  • Patch Test

Global Allergy Diagnostics And Therapeutics Market, By Drug Class

• Corticosteroids
• Mast Cell Stabilizers
• Antihistamines
• Decongestants
• Leukotriene Inhibitors
• Autoinjectable Epinephrine
• Nasal Anticholinergics
• Immunotherapy
• Immunomodulators

Global Allergy Diagnostics And Therapeutics Market, By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa (MEA)

The market research study on “Allergy Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Allergy Diagnostics And Therapeutics market segments with market dynamics and their impact. The report also covers basic technology development policies.

Key Players & Strategies

Some of the main worldwide businesses include Thermo Fisher Scientific, bioMerieux, Danaher Corporation, Stallergenes Greer, Omega Diagnostics, Siemens Healthcare, Hitachi Chemical Diagnostics, Hycor Biomedical and Alcon. The industry is extremely competitive and businesses are actively engaged in the launch of fresh products, strategic partnerships, procurement and development of technology to achieve maximum market share.

For example, the Medic Savoure Ltd. was acquired by Stallergenes Greer in October of 2017 and thus strengthened its presence on the immunotherapy market for allergies in Canada. In July 2016, FDA approval was also obtained from Novartis AG to use its Xolair product to treat allergic asthma in pediatrics that contributed to expanding its product portfolio.